Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

Tokai, Nao; Yoshida, Shuzo; Kotani, Takuya; Yoshikawa, Ayaka; Kimura, Yuko; Fujiki, Youhei; Matsumura, Yoko; Takeuchi, Tohru et al. · PLoS One · 2019

Where this comes from

Record sourced from PubMed, PMID 30699195.
Also identified by DOI 10.1371/journal.pone.0211750 and PMC identifier 6353179.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0202601.].

Read the full text

View on PubMed · Publisher (DOI)